Company News - VC and PE investment business - Medical and health professional investment - Shenzhen Efung Investment Management Co. Ltd.

发布时间: 2026 - 05 - 29

Monthly Health Read | May 2026

Since the beginning of 2026, China's capital markets have demonstrated remarkable resilience. In the first quarter, GDP grew 5.0% year-on-year, exceeding market expectations. Entering May, A-shares continued their strong momentum, with the Shanghai Composite Index breaking through 4,200 points to reach an 11-year high. The positive macro data and market sentiment have created a favorable window for high-quality companies to pursue capital raising and business expansion.Against this positive macro backdrop, several of Efung Capital's portfolio companies have seen intensive financing pro...

浏览次数：4

查看详情>>

发布时间: 2026 - 05 - 09

Biostar Pharma Accelerates Oncology Innovation Pipeline Development

BEIJING, CHINA, May 8, 2026 – Beijing Biostar Pharmaceuticals Co., Ltd. (2563.HK, "Biostar Pharma"), a biopharmaceutical company leveraging its synthetic biology R&D platform to develop innovative anticancer drugs with proprietary intellectual property, today announced that Baheal Pharmaceutical (301015.SZ) has subscribed to 25 million new shares issued by Biostar Pharma. Upon completion of the issuance, Biostar Pharma will receive HK$100 million in subscription proceeds, and Baheal Pharmaceutical will hold an aggregate of 29,170,800 shares, representing 7.49% of the Co...

浏览次数：3

查看详情>>

发布时间: 2026 - 05 - 06

Efung Capital's Zhu Pai Named to "RZ U45" China's Best Young Investment Figures List

Recently, the results of the "RZ U45" China's Best Young Investment Figures selection, hosted by RZ Media and RZ Research, were grandly announced. Zhu Pai, CEO of Efung Capital, stood out among numerous candidates with his profound industry insight and successfully made the list.The "RZ U45" is an authoritative selection in China's equity investment industry initiated by RZ Media and RZ Research, aiming to identify outstanding young investment leaders under the age of 45 who have demonstrated exceptional performance in China's equity investment sector. The selec...

浏览次数：4

查看详情>>

发布时间: 2026 - 04 - 30

CEO of Efung Capital Named to Investors.com's "2026·54 Best Young Investors" List |

Today, Investors.com officially released its "Investors.com 2026·54 Best Young Investors List". Mr. Pai Zhu, CEO of Efung Capital, stood out among numerous competitors and was named to the prestigious list, thanks to his profound industry insights and continuous deep cultivation in the biopharmaceutical field.This list is initiated by Investors.com in collaboration with the Investors Research Institute. It aims to recognize a new generation of investors who possess a unique combination of technological acumen, industrial insight, and innovative action du...

浏览次数：5

查看详情>>